R. Descourt

Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study

R. Corre, Laurent Greillier, H. Le Caer et al. · Journal of Clinical Oncology · 2016 · 401 citations

Overall survival with crizotinib and next-generation ALK inhibitors in <i>ALK</i>-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective study

M. Duruisseaux, Benjamin Besse, J. Cadranel et al. · Oncotarget · 2017 · 160 citations · Full text

Characteristics and Outcomes of Patients with Lung Cancer Harboring Multiple Molecular Alterations: Results from the IFCT Study Biomarkers France

Nicolas Guibert, Fabrice Barlési, R. Descourt et al. · Journal of Thoracic Oncology · 2017 · 63 citations

Prognostic Biomarkers, Advanced Lung Disease, Medicine +9

First‐line pembrolizumab for non–small cell lung cancer patients with PD‐L1 ≥50% in a multicenter real‐life cohort: The PEMBREIZH study

Karim Amrane, Margaux Geier, R. Corre et al. · Cancer Medicine · 2020 · 60 citations · Full text

Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial

Guy Meyer, Benjamin Besse, H. Doubre et al. · European Respiratory Journal · 2018 · 55 citations · Full text